Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead collects 5th priority review voucher as public advocacy group urged the company to relinquish it
Endpoints
Tue, 05/3/22 - 10:49 am
Gilead Sciences
COVID-19
remdesivir
priority review
Gilead dives deeper into NK cell therapies with Dragonfly deal
Pharmaforum
Tue, 05/3/22 - 10:37 am
Gilead Sciences
natural killer cells
Dragonfly Therapeutics
TriNKET
cancer
Gilead’s Covid-19 treatment Veklury props up first quarter gains amid $2.7B Trodelvy writedown
Endpoints
Fri, 04/29/22 - 10:31 am
Gilead Sciences
Veklury
remdesivir
earnings
Trodelvy
FDA approves first COVID treatment for children under 12
Axios
Mon, 04/25/22 - 11:02 pm
FDA
Gilead Sciences
Veklury
remdesivir
pediatric
Gilead touts analysis showing COVID antiviral Veklury performs best when given early in illness
Fierce Pharma
Mon, 04/25/22 - 10:21 am
Gilead Sciences
Veklury
COVID-19
remdesivir
WHO
Gilead presses HIV drug fraud in court, wins freeze of 'kingpin' assets
Fierce Pharma
Wed, 04/20/22 - 10:56 am
Gilead Sciences
fraud
HIV
PrEP
Truvada
Descovy
Kite’s Maryland CAR T-cell therapy site gets FDA go-ahead
Biopharma Reporter
Wed, 04/20/22 - 10:43 am
Kite Pharma
Gilead Sciences
FDA
CAR-T
drug manufacturing
Yescarta
Gilead, after setbacks, aims to pull a third of its revenue from oncology business by 2030
Fierce Pharma
Mon, 04/18/22 - 11:47 pm
Gilead Sciences
oncology
cancer
Yescarta
Trodelvy
Gilead's Immunomedics settles over-hyped ASCO data mishap for $4M
Endpoints
Mon, 04/18/22 - 10:44 am
Immunomedics
Gilead Sciences
ASCO
breast cancer
Bristol Myers settles HIV antitrust suit, but J&J, Gilead still await their day in court
Fierce Pharma
Fri, 04/15/22 - 01:54 pm
JNJ
Bristol Myers Squibb
Gilead Sciences
HIV
legal
anticompetitive practices
generics
Bristol Myers Squibb Foundation unites with Gilead to boost diversity among clinical trial investigators
Fierce Biotech
Wed, 04/13/22 - 05:08 pm
Bristol Myers Squibb Foundation
Gilead Sciences
clinical trials
diversity
Gilead’s CD47 trials freed of FDA hold—for the most part
Fierce Biotech
Mon, 04/11/22 - 07:23 pm
Gilead Sciences
clinical trials
CD47
magrolimab
acute myeloid leukemia
FDA
Gilead unveils pediatric drug development center in Ireland with 33 new jobs
Fierce Biotech
Wed, 04/6/22 - 07:42 pm
Gilead Sciences
Ireland
drug development
pediatric
Physician poll finds ultralong-acting regimens and home administration could transform HIV market
Fierce Pharma
Tue, 04/5/22 - 11:02 am
HIV
physicians
GSK
Gilead Sciences
ViiV Healthcare
Gilead beats BMS to FDA okay for early lymphoma CAR-T therapy
Pharmaforum
Mon, 04/4/22 - 10:18 am
Gilead Sciences
Kite Pharma
CAR-T
Bristol Myers Squibb
lymphoma
large B-cell lymphoma
'March-in' battles heat up as nonprofits petition HHS on 6 drugs as earlier petition awaits decision
Endpoints
Mon, 03/28/22 - 10:08 am
HHS
Bayh-Dole Act
drug pricing
Pfizer
Gilead Sciences
Xtandi
Paxlovid
Epclusa
Descovy
insulin
After layoffs, Gilead to build NJ hub that will employ up to 500
Fierce Pharma
Fri, 03/25/22 - 10:48 am
Gilead Sciences
New Jersey
hirings
Gilead to limit 340B discounts for hepatitis C drugs
Beckers Hospital Review
Wed, 03/16/22 - 11:28 pm
Gilead Sciences
340B
hepatitis B
Gilead to boost West Coast production muscle after revealing New Jersey layoffs
Fierce Pharma
Thu, 03/10/22 - 11:05 am
Gilead Sciences
drug manufacturing
California
That key Gilead breast cancer readout? Try 2024, and don't get your hopes up: analyst
Fierce Pharma
Wed, 03/9/22 - 10:51 am
Gilead Sciences
Trodelvy
breast cancer
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »